161 related articles for article (PubMed ID: 18269329)
1. Genodiversity of resistant Pseudomonas aeruginosa isolates in relation to antimicrobial usage density and resistance rates in intensive care units.
Jonas D; Meyer E; Schwab F; Grundmann H
Infect Control Hosp Epidemiol; 2008 Apr; 29(4):350-7. PubMed ID: 18269329
[TBL] [Abstract][Full Text] [Related]
2. [SARI: surveillance of antibiotic use and bacterial resistance in German intensive care units. Correlation between antibiotic use and the emergence of resistance].
Meyer E; Jonas D; Schwab F; Gastmeier P; Rüden H; Daschner FD
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Apr; 47(4):345-51. PubMed ID: 15205777
[TBL] [Abstract][Full Text] [Related]
3. Methicillin-resistant Staphylococcus aureus in German intensive care units during 2000-2003: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in Intensive Care Units).
Meyer E; Schwab F; Gastmeier P; Jonas D; Rueden H; Daschner FD
Infect Control Hosp Epidemiol; 2006 Feb; 27(2):146-54. PubMed ID: 16465631
[TBL] [Abstract][Full Text] [Related]
4. Emergence of resistance in Pseudomonas aeruginosa and Acinetobacter species after the use of antimicrobials for burned patients.
Ferreira AC; Gobara S; Costa SE; Sauaia N; Mamizuka EM; van der Heijden IM; Soares RE; Almeida GD; Fontana C; Levin AS
Infect Control Hosp Epidemiol; 2004 Oct; 25(10):868-72. PubMed ID: 15518031
[TBL] [Abstract][Full Text] [Related]
5. Comparison of susceptibility to beta-lactam antimicrobial agents among bacteria isolated from intensive care units.
Pierson CL; Friedman BA
Diagn Microbiol Infect Dis; 1992 Feb; 15(2 Suppl):19S-30S. PubMed ID: 1737439
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001).
Mutnick AH; Rhomberg PR; Sader HS; Jones RN
J Antimicrob Chemother; 2004 Feb; 53(2):290-6. PubMed ID: 14711839
[TBL] [Abstract][Full Text] [Related]
7. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period.
Hanberger H; Burman LG; Cars O; Erlandsson M; Gill H; Nilsson LE; Nordlinder D; Walther SM;
Acta Anaesthesiol Scand; 2007 Aug; 51(7):937-41. PubMed ID: 17635399
[TBL] [Abstract][Full Text] [Related]
8. Surveillance of antimicrobial use and antimicrobial resistance in German intensive care units (SARI): a summary of the data from 2001 through 2004.
Meyer E; Schwab F; Gastmeier P; Rueden H; Daschner FD
Infection; 2006 Dec; 34(6):303-9. PubMed ID: 17180583
[TBL] [Abstract][Full Text] [Related]
9. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
Lei YC; Wang HB; Sun ZY; Shen ZY
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
[TBL] [Abstract][Full Text] [Related]
10. Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital.
Jung R; Fish DN; Obritsch MD; MacLaren R
J Hosp Infect; 2004 Jun; 57(2):105-11. PubMed ID: 15183239
[TBL] [Abstract][Full Text] [Related]
11. Temporal changes in bacterial resistance in German intensive care units, 2001-2003: data from the SARI (surveillance of antimicrobial use and antimicrobial resistance in intensive care units) project.
Meyer E; Schwab F; Jonas D; Ruden H; Gastmeier P; Daschner FD
J Hosp Infect; 2005 Aug; 60(4):348-52. PubMed ID: 15923060
[TBL] [Abstract][Full Text] [Related]
12. Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.
Fournier D; Richardot C; Müller E; Robert-Nicoud M; Llanes C; Plésiat P; Jeannot K
J Antimicrob Chemother; 2013 Aug; 68(8):1772-80. PubMed ID: 23587654
[TBL] [Abstract][Full Text] [Related]
13. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
[TBL] [Abstract][Full Text] [Related]
14. Changes in the rates of antimicrobial resistance among clinical isolates of Pseudomonas aeruginosa between 2002 and 2004 in a tertiary-care teaching hospital in Turkey.
Işeri L; Bayraktar MR
New Microbiol; 2008 Jul; 31(3):351-5. PubMed ID: 18843889
[TBL] [Abstract][Full Text] [Related]
15. Effect of a program to reduce hospital ciprofloxacin use on nosocomial Pseudomonas aeruginosa susceptibility to quinolones and other antimicrobial agents.
Cook PP; Das TD; Gooch M; Catrou PG
Infect Control Hosp Epidemiol; 2008 Aug; 29(8):716-22. PubMed ID: 18590455
[TBL] [Abstract][Full Text] [Related]
16. Contribution of clonal dissemination and selection of mutants during therapy to Pseudomonas aeruginosa antimicrobial resistance in an intensive care unit setting.
Juan C; Gutiérrez O; Oliver A; Ayestarán JI; Borrell N; Pérez JL
Clin Microbiol Infect; 2005 Nov; 11(11):887-92. PubMed ID: 16216103
[TBL] [Abstract][Full Text] [Related]
17. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
[TBL] [Abstract][Full Text] [Related]
18. Decreased resistance of Pseudomonas aeruginosa with restriction of ciprofloxacin in a large teaching hospital's intensive care and intermediate care units.
Lewis GJ; Fang X; Gooch M; Cook PP
Infect Control Hosp Epidemiol; 2012 Apr; 33(4):368-73. PubMed ID: 22418632
[TBL] [Abstract][Full Text] [Related]
19. Impact of ertapenem use on Pseudomonas aeruginosa and Acinetobacter baumannii imipenem susceptibility rates: collateral damage or positive effect on hospital ecology?
Sousa D; Castelo-Corral L; Gutiérrez-Urbón JM; Molina F; López-Calviño B; Bou G; Llinares P
J Antimicrob Chemother; 2013 Aug; 68(8):1917-25. PubMed ID: 23557925
[TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with resistance to ciprofloxacin in clinical bacterial isolates from intensive care unit patients.
Levin PD; Fowler RA; Guest C; Sibbald WJ; Kiss A; Simor AE
Infect Control Hosp Epidemiol; 2007 Mar; 28(3):331-6. PubMed ID: 17326025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
